Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Magnetic Resonance Imaging : JMRI
|
January 4, 2018
Signal enhancement ratio imaging of the lung parenchyma with ultra-fast steady-state free precession MRI at 1.5T
Orso Pusterla, Gregor Sommer, Francesco Santini, et al.
Infection
|
December 2, 2015
An unexpected cause for cavitary pneumonia and empyema
Constantine Bloch-Infanger, Katarzyna Furrer, Mark Wiese, et al.
Journal of Thoracic Disease
|
April 15, 2024
Perioperative intravenous lidocaine in thoracoscopic surgery for improved postoperative pain control: a randomized, placebo-controlled, double-blind, superiority trial
Aljaz Hojski, Daniel Bolliger, Makhmudbek Mallaev, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2022
Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study
Anna Kaumanns, David König, Aljaz Hojski, et al.
Contrast Media & Molecular Imaging
|
February 3, 2018
The Spatial Relationship between Apparent Diffusion Coefficient and Standardized Uptake Value of <sup>18</sup>F-Fluorodeoxyglucose Has a Crucial Influence on the Numeric Correlation of Both Parameters in PET/MRI of Lung Tumors
Alexander W Sauter, Bram Stieltjes, Thomas Weikert, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2020
PD-1<sup>+</sup> natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade
Marcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.
Nature Medicine
|
June 13, 2018
A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S Thommen, Viktor H Koelzer, Petra Herzig, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Marina Natoli, Klas Hatje, Pratiksha Gulati, et al.
Journal for Immunotherapy of Cancer
|
July 4, 2020
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
Marta Trüb, Franziska Uhlenbrock, Christina Claus, et al.
Nature Communications
|
February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Marcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Magnetic Resonance Imaging : JMRI
|
January 4, 2018
Signal enhancement ratio imaging of the lung parenchyma with ultra-fast steady-state free precession MRI at 1.5T
Orso Pusterla, Gregor Sommer, Francesco Santini, et al.
Infection
|
December 2, 2015
An unexpected cause for cavitary pneumonia and empyema
Constantine Bloch-Infanger, Katarzyna Furrer, Mark Wiese, et al.
Journal of Thoracic Disease
|
April 15, 2024
Perioperative intravenous lidocaine in thoracoscopic surgery for improved postoperative pain control: a randomized, placebo-controlled, double-blind, superiority trial
Aljaz Hojski, Daniel Bolliger, Makhmudbek Mallaev, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2022
Role of 18F-FDG PET/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study
Anna Kaumanns, David König, Aljaz Hojski, et al.
Contrast Media & Molecular Imaging
|
February 3, 2018
The Spatial Relationship between Apparent Diffusion Coefficient and Standardized Uptake Value of <sup>18</sup>F-Fluorodeoxyglucose Has a Crucial Influence on the Numeric Correlation of Both Parameters in PET/MRI of Lung Tumors
Alexander W Sauter, Bram Stieltjes, Thomas Weikert, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2020
PD-1<sup>+</sup> natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade
Marcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.
Nature Medicine
|
June 13, 2018
A transcriptionally and functionally distinct PD-1<sup>+</sup> CD8<sup>+</sup> T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S Thommen, Viktor H Koelzer, Petra Herzig, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2022
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Marina Natoli, Klas Hatje, Pratiksha Gulati, et al.
Journal for Immunotherapy of Cancer
|
July 4, 2020
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
Marta Trüb, Franziska Uhlenbrock, Christina Claus, et al.
Nature Communications
|
February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Marcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Page
of 2